Literature DB >> 14654750

Capillary rarefaction and abnormal cardiovascular reactivity in hypertension.

Giovanni Ciuffetti1, Giuseppe Schillaci, Salvatore Innocente, Rita Lombardini, Leonella Pasqualini, Salvatore Notaristefano, Elmo Mannarino.   

Abstract

OBJECTIVE: To determine the effects of capillary rarefaction on cardiovascular reactivity and microcirculatory functioning in essential hypertension.
DESIGN: Hypertension is associated with abnormal cardiovascular reactivity and increased vasoconstriction. Capillary rarefaction amplifies these abnormalities, which modify microcirculatory hemodynamics. Hence this study of the hemorheological pattern and the veno-arteriolar reflex in hypertensive patients and normotensive control subjects.
METHODS: Sixty-one men with never-treated essential hypertension and capillary rarefaction (< 80 capillaries per field) and 20 age-matched and sex-matched controls underwent a strenuous cycle ergometer test to monitor, during exercise and recovery, the blood pressure profile and the hemorheological pattern: blood viscosity at low shear, hematocrit and leukocyte counts, soluble P-selectin levels, and red and white blood cell filterability rates. The veno-arteriolar reflex was determined by laser-Doppler flowmetry before exercise and at recovery.RESULTS Hypertensive men with < or = 72 capillaries per field had an abnormal hemorheological profile before exercise. The physiological response to exercise was observed only in the controls and in hypertensives with > or = 73 capillaries per field. Abnormal responses to exercise worsened as capillaries were more rarefied. At recovery, hemorheological parameters in hypertensives with 65-72 capillaries per field returned to baseline, remaining significantly (P < 0.05) different to control values. Variations in the hemorheological pattern in hypertensives with < 64 capillary per field persisted at recovery. The veno-arteriolar reflex followed the same pattern.
CONCLUSION: A reduced microvascular network may contribute to abnormal cardiovascular reactivity and to exercise-induced rheological abnormalities in hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654750     DOI: 10.1097/00004872-200312000-00018

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  13 in total

Review 1.  Adverse effects of anticancer agents that target the VEGF pathway.

Authors:  Helen X Chen; Jessica N Cleck
Journal:  Nat Rev Clin Oncol       Date:  2009-07-07       Impact factor: 66.675

Review 2.  Vascular endothelial growth factor polymorphisms: role in response and toxicity of tyrosine kinase inhibitors.

Authors:  Susan A J Vaziri; Jenny Kim; Mahrukh K Ganapathi; Ram Ganapathi
Journal:  Curr Oncol Rep       Date:  2010-03       Impact factor: 5.075

3.  Quantitative and functional characteristics of endothelial progenitor cells in newly diagnosed hypertensive patients.

Authors:  M Skrzypkowska; J Myśliwska; B Słomiński; J Siebert; P Gutknecht; M Ryba-Stanisławowska
Journal:  J Hum Hypertens       Date:  2014-10-09       Impact factor: 3.012

Review 4.  Redox signaling, vascular function, and hypertension.

Authors:  Moo Yeol Lee; Kathy K Griendling
Journal:  Antioxid Redox Signal       Date:  2008-06       Impact factor: 8.401

Review 5.  The role of exercise in the reversal of IGF-1 deficiencies in microvascular rarefaction and hypertension.

Authors:  Amani M Norling; Adam T Gerstenecker; Thomas W Buford; Bilal Khan; Suzanne Oparil; Ronald M Lazar
Journal:  Geroscience       Date:  2019-12-05       Impact factor: 7.713

6.  Impaired training-induced adaptation of blood pressure in COPD patients: implication of the muscle capillary bed.

Authors:  Fares Gouzi; Jonathan Maury; François Bughin; Marine Blaquière; Bronia Ayoub; Jacques Mercier; Antonia Perez-Martin; Pascal Pomiès; Maurice Hayot
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-22

7.  Left Ventricular Torsion Associated With Aortic Stiffness in Hypertension.

Authors:  Jean-Barthelemy Gnakamene; Michel E Safar; Bernard I Levy; Brigitte Escoubet
Journal:  J Am Heart Assoc       Date:  2018-02-28       Impact factor: 5.501

8.  Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.

Authors:  D A Reardon; A Desjardins; J J Vredenburgh; S Gururangan; J H Sampson; S Sathornsumetee; R E McLendon; J E Herndon; J E Marcello; J Norfleet; A H Friedman; D D Bigner; H S Friedman
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

9.  Endothelial nitric oxide synthase Glu298Asp gene polymorphism is associated with hypertensive response to exercise in well-controlled hypertensive patients.

Authors:  Jung-Sun Kim; Jung Rae Cho; Sungha Park; Jaemin Shim; Jin-Bae Kim; Deok-Kyu Cho; Hyun-Joon Shin; Chan Mi Park; Young-Guk Ko; Jong-Won Ha; Donghoon Choi; Se-Joong Rim; Yangsoo Jang; Namsik Chung
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

10.  Hypertension from the perspective of Iranian traditional medicine.

Authors:  Roshanak Ghods; Manouchehr Gharooni; Gholamreza Amin; Esmaeil Nazem; Alireza Nikbakht Nasrabadi
Journal:  Iran Red Crescent Med J       Date:  2014-03-05       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.